Pharmacovigilance: Partnering for Patient Safety

Dr. Shanthi Pal

Programme Manager for Pharmacovigilance Quality Assurance and Safety of Medicines, World Health Organization

N/A

Dr. Fermin Ruiz de Erenchun

IFPMA Biotherapeutics Group Chair (F. Hoffmann-La Roche)

Fermin Ruiz de Erenchun studied Medicine in the University of Navarra (Pamplona, Spain). He holds a degree in dermatology, and a doctorate from the University Clinic of Navarra. In 1993, he joined Hoffmann La Roche’s Spanish office, then in 1999 moved to Roche’s corporate headquarter in Basel (Switzerland). Between 2008 and 2010, he was General Management of Roche Peru in Lima. During the last 3 years, he has been engaged in meeting with National Regulatory Agencies in Europe and around the world to discuss and contribute to the implementation of biosimilar pathways. Since 2011, he chairs the biotherapeutic group at the International Federation of Pharmaceutical Manufactures & Associations (IFPMA) in Geneva, Switzerland.

Dr. Jeremiah Mwangi

Policy and External Affairs Director International Alliance of Patients’ Organizations

N/A

Dr. Otmar Kloiber

Secretary General World Medical Association

Dr Otmar Kloiber was appointed as Secretary General of the World Medical Association in February 2005. Before joining the WMA, Dr Kloiber served as Deputy Secretary General of the German Medical Association. As WMA Secretary General, he is the head of its Secretariat and is responsible for managing and directing the WMA staff and the activities of the WMA. He provides overall leadership and strategic direction to the organisation and represents the WMA to the Association's members, the medical profession, the international community, representatives of government, the business community, and the public.